Abstract
Overview
Introduction
The Canadian pharmaceutical market is the 8th largest globally and as such
represents an important market for generics manufacturers. Although
historically dominated by domestic generics companies, mergers and
acquisitions over the last five years have increased the dominance of foreign
players.
Scope
- Overview of the size of the Canadian generics market
- Review of the leading drug classes driving generic sales growth
- Assessment of the key drivers and resistors affecting the Canadian
generics market
- Profiles of the leading companies in the Canadian generics market
Report Highlights
The Canadian generics sector has grown more rapidly than the pharmaceutical
market as a whole over recent years. However, this growth has not been driven
by significant volume increases or price rises, instead it has been a number
of recent launches of new generics of high selling brands that have altered
the product mix.
Domestic generics manufacturers have historically had an advantage in this
market however overseas players have increased there presence through
acquisitions over recent years to enable them to benefit from the same
advantages.
Reasons to Purchase
- Assess the size of the Canadian generics market and the key therapeutic
classes that are driving growth
- Examine the growth drivers and resistors that are shaping this significant
generics market
- Benchmark the key companies operating in the Canadian generics market
View Cart
